1
|
Wang Y, Xu K, Liu H, Zhang W, Hu C, Li Y. Design, synthesis of auristatins-glucuronide conjugates targeting the β-glucuronidase in tumor microenvironment. Bioorg Med Chem Lett 2023; 95:129493. [PMID: 37793497 DOI: 10.1016/j.bmcl.2023.129493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 09/19/2023] [Accepted: 10/01/2023] [Indexed: 10/06/2023]
Abstract
Auristatins-glucuronide conjugates designed targeting the β-Glucuronidase in tumor microenvironment were synthesized and evaluated on stabilities, the release of auristatins and the antitumor activities in this study. Conjugates 20 and 21 showed remarkable stabilities in phosphate buffer and bovine serum solution, and excellent selectivity between the in vitro antiproliferative activities against β-glucuronidase pretreated and untreated cancer cells (IC50 = 5.7 nM ∼ 9.7 nM, IC50 (-Enz) > 1 μM). Furthermore, conjugate 20 showed potent antitumor efficacy in HCT-116 xenograft mouse model without inducing side effects.
Collapse
Affiliation(s)
- Yujie Wang
- School of Pharmacy, Fudan University, Shanghai 201203, China
| | - Keshi Xu
- Key Laboratory of Structure-based Drug Design & Discovery, Ministry of Education of China, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Hongchun Liu
- Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Wei Zhang
- Key Laboratory of Structure-based Drug Design & Discovery, Ministry of Education of China, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Chun Hu
- Key Laboratory of Structure-based Drug Design & Discovery, Ministry of Education of China, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
| | - Yingxia Li
- School of Pharmacy, Fudan University, Shanghai 201203, China.
| |
Collapse
|
2
|
Peng Y, Shi Z, Liang Y, Ding K, Wang Y. Targeting the tumor microenvironment by an enzyme-responsive prodrug of tubulin destabilizer for triple-negative breast cancer therapy with high safety. Eur J Med Chem 2022; 236:114344. [PMID: 35405397 DOI: 10.1016/j.ejmech.2022.114344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 03/21/2022] [Accepted: 03/31/2022] [Indexed: 11/04/2022]
Abstract
In response to the long-term potential toxicity concerns of tubulin destabilizer, an enzyme-responsive prodrug therapy for triple-negative breast cancer was developed based on the different β-glucuronidase levels between tumor and normal tissues in this study. All the prodrugs synthesized herein showed remarkable stability in phosphate buffer and bovine serum solution, among which 17a was found to be more susceptible to enzymatic cleavage. 17a exhibited excellent selectivity between the in vitro antiproliferative activities against β-glucuronidase-pretreated and -untreated cancer cells (IC50 (+Enz) = 8.9-15.7 nM, IC50 (-Enz) > 50 μM), along with favorable liver microsomal metabolic stability and improved aqueous solubility. Furthermore, as a candidate prodrug 17a showed potent antitumor efficacy in MDA-MB-231 xenograft mouse model without causing perceptible injury to organs. Importantly, 17a exhibited superior safety profiles with higher LD50 value and no perceivable cardiotoxicity, which was a major dose-limiting adverse effect for the parent compound 1. These salient toxicity-reduced effects of 17a would merit further in-depth assessment of this compound for preclinical therapeutic usages.
Collapse
Affiliation(s)
- Yingyuan Peng
- School of Pharmacy, Fudan University, Shanghai, 201203, China
| | - Zhixian Shi
- School of Pharmacy, Fudan University, Shanghai, 201203, China
| | - Yuru Liang
- State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, China
| | - Kuiling Ding
- State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, China.
| | - Yang Wang
- School of Pharmacy, Fudan University, Shanghai, 201203, China; School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China; Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, China.
| |
Collapse
|
3
|
Gavriel A, Sambrook M, Russell AT, Hayes W. Recent advances in self-immolative linkers and their applications in polymeric reporting systems. Polym Chem 2022. [DOI: 10.1039/d2py00414c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Interest in self-immolative chemistry has grown over the past decade with more research groups harnessing the versatility to control the release of a compound from a larger chemical entity, given...
Collapse
|
4
|
Martin H, Lázaro LR, Gunnlaugsson T, Scanlan EM. Glycosidase activated prodrugs for targeted cancer therapy. Chem Soc Rev 2022; 51:9694-9716. [DOI: 10.1039/d2cs00379a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
In this review glycosidase activated prodrugs that target cancer cells are discussed.
Collapse
Affiliation(s)
- Harlei Martin
- School of Chemistry and Trinity Bioscience Institute, The University of Dublin, Trinity College Dublin, Dublin 2, Ireland
| | - Laura Ramírez Lázaro
- School of Chemistry and Trinity Bioscience Institute, The University of Dublin, Trinity College Dublin, Dublin 2, Ireland
- SFI Synthesis and Solid State Pharmaceutical Centre (SSPC), Ireland
| | - Thorfinnur Gunnlaugsson
- School of Chemistry and Trinity Bioscience Institute, The University of Dublin, Trinity College Dublin, Dublin 2, Ireland
- SFI Synthesis and Solid State Pharmaceutical Centre (SSPC), Ireland
| | - Eoin M. Scanlan
- School of Chemistry and Trinity Bioscience Institute, The University of Dublin, Trinity College Dublin, Dublin 2, Ireland
- SFI Synthesis and Solid State Pharmaceutical Centre (SSPC), Ireland
| |
Collapse
|
5
|
Pettinato MC. Introduction to Antibody-Drug Conjugates. Antibodies (Basel) 2021; 10:antib10040042. [PMID: 34842621 PMCID: PMC8628511 DOI: 10.3390/antib10040042] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 07/30/2021] [Accepted: 10/06/2021] [Indexed: 02/05/2023] Open
Abstract
Antibody-drug conjugates (ADCs) are innovative biopharmaceutical products in which a monoclonal antibody is linked to a small molecule drug with a stable linker. Most of the ADCs developed so far are for treating cancer, but there is enormous potential for using ADCs to treat other diseases. Currently, ten ADCs have been approved by the United States Food and Drug Administration (FDA), and more than 90 ADCs are under worldwide clinical development. Monoclonal antibodies have evolved from research tools to powerful therapeutics in the past 30 years. Tremendous strides have been made in antibody discovery, protein bioengineering, formulation, and delivery devices. This manuscript provides an overview of the biology, chemistry, and biophysical properties of each component of ADC design. This review summarizes the advances and challenges in the field to date, with an emphasis on antibody conjugation, linker-payload chemistry, novel payload classes, drug-antibody ratio (DAR), and product development. The review emphasizes the lessons learned in the development of oncology antibody conjugates and look towards future innovations enabling other therapeutic indications. The review discusses resistance mechanisms to ADCs, and give an opinion on future perspectives.
Collapse
Affiliation(s)
- Mark C Pettinato
- Department of Biomedical Engineering, School of Engineering, Catholic University of America, 620 Michigan Avenue NE, Washington, DC 20064-0001, USA
| |
Collapse
|
6
|
Yang X, Pan Z, Choudhury MR, Yuan Z, Anifowose A, Yu B, Wang W, Wang B. Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery. Med Res Rev 2020; 40:2682-2713. [PMID: 32803765 PMCID: PMC7817242 DOI: 10.1002/med.21720] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 07/23/2020] [Accepted: 08/02/2020] [Indexed: 12/14/2022]
Abstract
Smart drugs, such as antibody-drug conjugates, for targeted therapy rely on the ability to deliver a warhead to the desired location and to achieve activation at the same site. Thus, designing a smart drug often requires proper linker chemistry for tethering the warhead with a vehicle in such a way that either allows the active drug to retain its potency while being tethered or ensures release and thus activation at the desired location. Recent years have seen much progress in the design of new linker activation strategies. Herein, we review the recent development of chemical strategies used to link the warhead with a delivery vehicle for preferential cleavage at the desired sites.
Collapse
Affiliation(s)
| | | | - Manjusha Roy Choudhury
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| | - Zhengnan Yuan
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| | - Abiodun Anifowose
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| | - Bingchen Yu
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| | - Wenyi Wang
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| | - Binghe Wang
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States
| |
Collapse
|
7
|
Gonzaga RV, do Nascimento LA, Santos SS, Machado Sanches BA, Giarolla J, Ferreira EI. Perspectives About Self-Immolative Drug Delivery Systems. J Pharm Sci 2020; 109:3262-3281. [DOI: 10.1016/j.xphs.2020.08.014] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Revised: 07/27/2020] [Accepted: 08/17/2020] [Indexed: 12/14/2022]
|
8
|
Porte K, Renoux B, Péraudeau E, Clarhaut J, Eddhif B, Poinot P, Gravel E, Doris E, Wijkhuisen A, Audisio D, Papot S, Taran F. Controlled Release of a Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angew Chem Int Ed Engl 2019; 58:6366-6370. [DOI: 10.1002/anie.201902137] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Indexed: 12/25/2022]
Affiliation(s)
- Karine Porte
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Brigitte Renoux
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Elodie Péraudeau
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
- CHU de Poitiers 86021 Poitiers France
| | - Jonathan Clarhaut
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
- CHU de Poitiers 86021 Poitiers France
| | - Balkis Eddhif
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Pauline Poinot
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Edmond Gravel
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Eric Doris
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Anne Wijkhuisen
- Service de Pharmacologie et d'Immunoanalyse DRF-JOLIOT-SPICEAUniversité Paris-Saclay 91191 Gif-sur-Yvette France
| | - Davide Audisio
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Sébastien Papot
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Frédéric Taran
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| |
Collapse
|
9
|
Porte K, Renoux B, Péraudeau E, Clarhaut J, Eddhif B, Poinot P, Gravel E, Doris E, Wijkhuisen A, Audisio D, Papot S, Taran F. Controlled Release of a Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201902137] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
- Karine Porte
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Brigitte Renoux
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Elodie Péraudeau
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
- CHU de Poitiers 86021 Poitiers France
| | - Jonathan Clarhaut
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
- CHU de Poitiers 86021 Poitiers France
| | - Balkis Eddhif
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Pauline Poinot
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Edmond Gravel
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Eric Doris
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Anne Wijkhuisen
- Service de Pharmacologie et d'Immunoanalyse DRF-JOLIOT-SPICEAUniversité Paris-Saclay 91191 Gif-sur-Yvette France
| | - Davide Audisio
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| | - Sébastien Papot
- Université de PoitiersUMR-CNRS 7285Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) 86073 Poitiers France
| | - Frédéric Taran
- Service de Chimie Bio-organique et Marquage DRF-JOLIOT-SCBMCEA, Université Paris-Saclay 91191 Gif-sur-Yvette France
| |
Collapse
|
10
|
Brissonnet Y, Compain G, Renoux B, Krammer EM, Daligault F, Deniaud D, Papot S, Gouin SG. Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase. RSC Adv 2019; 9:40263-40267. [PMID: 35542663 PMCID: PMC9076263 DOI: 10.1039/c9ra08847d] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 11/18/2019] [Indexed: 12/15/2022] Open
Abstract
Enzymatically-triggered probes to determine glucuronidase hydrolysis kinetics for clustered substrates.
Collapse
Affiliation(s)
- Yoan Brissonnet
- Université de Nantes
- CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation
- UMR CNRS 6230
- UFR des Sciences et des Techniques
- 44322 Nantes Cedex 3
| | - Guillaume Compain
- Institut de Chimie des Milieux et des Matériaux de Poitiers
- IC2MP
- Université de Poitiers
- UMR-CNRS 7285
- 86022 Poitiers
| | - Brigitte Renoux
- Institut de Chimie des Milieux et des Matériaux de Poitiers
- IC2MP
- Université de Poitiers
- UMR-CNRS 7285
- 86022 Poitiers
| | - Eva-Maria Krammer
- Structure et Fonction des Membranes Biologiques
- Université Libre de Bruxelles (ULB)
- Brussels
- Belgium
| | - Franck Daligault
- Université de Nantes
- UFIP
- UMR CNRS 6286
- UFR des Sciences et des Techniques
- France
| | - David Deniaud
- Université de Nantes
- CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation
- UMR CNRS 6230
- UFR des Sciences et des Techniques
- 44322 Nantes Cedex 3
| | - Sébastien Papot
- Institut de Chimie des Milieux et des Matériaux de Poitiers
- IC2MP
- Université de Poitiers
- UMR-CNRS 7285
- 86022 Poitiers
| | - Sébastien G. Gouin
- Université de Nantes
- CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation
- UMR CNRS 6230
- UFR des Sciences et des Techniques
- 44322 Nantes Cedex 3
| |
Collapse
|
11
|
Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy. Eur J Med Chem 2017; 142:393-415. [DOI: 10.1016/j.ejmech.2017.08.049] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Revised: 08/21/2017] [Accepted: 08/22/2017] [Indexed: 11/20/2022]
|
12
|
Renoux B, Raes F, Legigan T, Péraudeau E, Eddhif B, Poinot P, Tranoy-Opalinski I, Alsarraf J, Koniev O, Kolodych S, Lerondel S, Le Pape A, Clarhaut J, Papot S. Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chem Sci 2017; 8:3427-3433. [PMID: 28507714 PMCID: PMC5417048 DOI: 10.1039/c7sc00472a] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2017] [Accepted: 03/01/2017] [Indexed: 12/21/2022] Open
Abstract
The development of novel therapeutic strategies allowing the destruction of tumour cells while sparing healthy tissues is one of the main challenges of cancer chemotherapy. Here, we report on the design and antitumour activity of a low-molecular-weight drug delivery system programmed for the selective release of the potent monomethylauristatin E in the tumour microenvironment of solid tumours. After intravenous administration, this compound binds covalently to plasmatic albumin through Michael addition, thereby enabling its passive accumulation in tumours where extracellular β-glucuronidase initiates the selective release of the drug. This targeting device produces outstanding therapeutic efficacy on orthotopic triple-negative mammary and pancreatic tumours in mice (50% and 33% of mice with the respective tumours cured), leading to impressive reduction or even disappearance of tumours without inducing side effects.
Collapse
Affiliation(s)
- Brigitte Renoux
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
| | - Florian Raes
- UPS no. 44 PHENOMIN TAAM-CIPA , CNRS , 3B rue de la Férollerie , F-45071 Orléans , France
| | - Thibaut Legigan
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
| | - Elodie Péraudeau
- Université de Poitiers , CNRS , ERL 7368, 1 rue Georges Bonnet, TSA 51106 , F-86073 Poitiers , France
- CHU de Poitiers , 2 rue de la Miléterie, CS 90577 , F-86021 Poitiers , France
| | - Balkis Eddhif
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Equipe Eau, Géochimie Organique, Santé (EGS), 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France
| | - Pauline Poinot
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Equipe Eau, Géochimie Organique, Santé (EGS), 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France
| | - Isabelle Tranoy-Opalinski
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
| | - Jérôme Alsarraf
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
| | - Oleksandr Koniev
- Syndivia SAS , 650 Bd Gonthier d'Andernach , 67400 Illkirch , France
| | - Sergii Kolodych
- Syndivia SAS , 650 Bd Gonthier d'Andernach , 67400 Illkirch , France
| | - Stéphanie Lerondel
- UPS no. 44 PHENOMIN TAAM-CIPA , CNRS , 3B rue de la Férollerie , F-45071 Orléans , France
| | - Alain Le Pape
- UPS no. 44 PHENOMIN TAAM-CIPA , CNRS , 3B rue de la Férollerie , F-45071 Orléans , France
| | - Jonathan Clarhaut
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
- CHU de Poitiers , 2 rue de la Miléterie, CS 90577 , F-86021 Poitiers , France
| | - Sébastien Papot
- Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP) , Université de Poitiers , CNRS , Groupe "Systèmes Moléculaires Programmés" , 4 rue Michel Brunet, TSA 51106 , F-86073 Poitiers , France .
| |
Collapse
|
13
|
Izmest’ev ES, Andreeva OV, Sharipova RR, Kravchenko MA, Garifullin BF, Strobykina IY, Kataev VE, Mironov VF. Synthesis and antitubercular activity of first glucuronosyl phosphates and amidophosphates containing polymethylene chains. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2017. [DOI: 10.1134/s1070428017010092] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
14
|
Kacprzak K, Skiera I, Piasecka M, Paryzek Z. Alkaloids and Isoprenoids Modification by Copper(I)-Catalyzed Huisgen 1,3-Dipolar Cycloaddition (Click Chemistry): Toward New Functions and Molecular Architectures. Chem Rev 2016; 116:5689-743. [DOI: 10.1021/acs.chemrev.5b00302] [Citation(s) in RCA: 176] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Karol Kacprzak
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Ul. Umultowska 89b, 61-614 Poznań, Poland
| | - Iwona Skiera
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Ul. Umultowska 89b, 61-614 Poznań, Poland
| | - Monika Piasecka
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Ul. Umultowska 89b, 61-614 Poznań, Poland
| | - Zdzisław Paryzek
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Ul. Umultowska 89b, 61-614 Poznań, Poland
| |
Collapse
|
15
|
Bensalma S, Chadeneau C, Legigan T, Renoux B, Gaillard A, de Boisvilliers M, Pinet-Charvet C, Papot S, Muller JM. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors. J Mol Neurosci 2014; 55:51-61. [PMID: 25280457 DOI: 10.1007/s12031-014-0395-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Accepted: 07/29/2014] [Indexed: 12/27/2022]
Abstract
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. Activation of the developmental hedgehog (Hh) pathway is observed in GBM, particularly in the so-called glioma stem cells (GSCs). An inhibitor of this pathway is the steroidal alkaloid cyclopamine, an antagonist of the Hh coreceptor Smoothened (SMO). To limit the toxicity of cyclopamine toward Hh-dependent non-tumor cells, our group previously reported the synthesis of a prodrug (called 1b), designed to deliver cyclopamine in the presence of β-glucuronidase, an enzyme found in the necrotic area of GBM. Here, we aimed to analyze the in vitro, ex vivo, and in vivo cytotoxic properties of this prodrug in the C6 rat GBM cells. In the presence of β-glucuronidase, the activated prodrug 1b was toxic and downregulated expression of Gli1, a Hh target gene, in C6 cells and C6-GSCs, but not in normal rat astrocytes in which the Hh pathway is weakly activated. In the absence of β-glucuronidase, prodrug 1b displayed no obvious toxicity toward rat brain tissue explants while cyclopamine clearly affected brain tissue viability. When administered to rats bearing fluorescent C6-derived GBM, the prodrug 1b reduced the tumor density more efficiently than cyclopamine. Prodrug 1b thus appears as a promising concept to optimize confinement of cyclopamine cytotoxicity within the tumors, with more limited effects in the surrounding normal brain tissue.
Collapse
Affiliation(s)
- Souheyla Bensalma
- "Récepteurs, Régulations et Cellules Tumorales" (2RCT) Group, Université de Poitiers, 1 Rue Georges Bonnet, 86022, Poitiers, France.,CNRS FRE 3511, Université de Poitiers, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Corinne Chadeneau
- "Récepteurs, Régulations et Cellules Tumorales" (2RCT) Group, Université de Poitiers, 1 Rue Georges Bonnet, 86022, Poitiers, France.,CNRS FRE 3511, Université de Poitiers, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Thibaut Legigan
- Institut de Chimie des Milieux et des Matériaux (IC2MP), Université de Poitiers, UMR-CNRS 7285, 4 Rue Michel Brunet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Brigitte Renoux
- Institut de Chimie des Milieux et des Matériaux (IC2MP), Université de Poitiers, UMR-CNRS 7285, 4 Rue Michel Brunet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Afsaneh Gaillard
- Laboratoire des Neurosciences Expérimentales et Cliniques (LNEC), Université de Poitiers, INSERM U 1084, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Madryssa de Boisvilliers
- "Récepteurs, Régulations et Cellules Tumorales" (2RCT) Group, Université de Poitiers, 1 Rue Georges Bonnet, 86022, Poitiers, France.,CNRS FRE 3511, Université de Poitiers, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Caroline Pinet-Charvet
- CNRS FRE 3511, Université de Poitiers, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Sébastien Papot
- Institut de Chimie des Milieux et des Matériaux (IC2MP), Université de Poitiers, UMR-CNRS 7285, 4 Rue Michel Brunet, TSA 51106, 86073, Poitiers Cedex 9, France
| | - Jean Marc Muller
- "Récepteurs, Régulations et Cellules Tumorales" (2RCT) Group, Université de Poitiers, 1 Rue Georges Bonnet, 86022, Poitiers, France. .,CNRS FRE 3511, Université de Poitiers, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France.
| |
Collapse
|
16
|
Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Mol Cancer Ther 2014; 13:2159-69. [PMID: 25053823 DOI: 10.1158/1535-7163.mct-13-1038] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Recent data suggest that inhibition of the Hedgehog pathway could be a therapeutic target for glioblastoma. Alkaloid cyclopamine inhibits Hedgehog signaling, depleting stem-like cancer cells derived from glioblastoma. However, this compound is toxic for somatic stem cells, preventing its use for clinical applications. In this study, we tested a derivatization product of cyclopamine in the form of cyclopamine glucuronide prodrug (CGP-2). This compound was used in vitro and in vivo toward glioblastoma-initiating cells (GIC). Results obtained in vitro indicate that CGP-2 is active only in the presence of β-glucuronidase, an enzyme detected in high levels in necrotic areas of glioblastomas. CGP-2 decreased proliferation and inhibited the self-renewal of all GIC lines tested. Hedgehog pathway blockade by 10 μmol/L of CGP-2 induced a 99% inhibition of clonogenicity on GICs, similar to cyclopamine treatment. Combination of CGP-2 with radiation decreased clonogenic survival in all GIC lines compared with CGP-2 alone. In a subcutaneous glioblastoma xenograft model, a two-week CGP-2 treatment prevented tumor growth with 75% inhibition at 8 weeks, and this inhibition was still significant after 14 weeks. Unlike cyclopamine, CGP-2 had no detectable toxic effects in intestinal crypts. Our study suggests that inhibition of the Hedgehog pathway with CGP-2 is more effective than conventional temozolomide adjuvant, with much lower concentrations, and seems to be an effective therapeutic strategy for targeting GICs.
Collapse
Affiliation(s)
- Anaïs Balbous
- INSERMU935, Modèles de cellules souches malignes et thérapeutiques, Poitiers, France. Université de Poitiers, Poitiers, France. CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France
| | - Brigitte Renoux
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux, Groupe «Systèmes Moléculaires Programmés, Poitiers, France
| | - Ulrich Cortes
- INSERMU935, Modèles de cellules souches malignes et thérapeutiques, Poitiers, France. Université de Poitiers, Poitiers, France. CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France
| | - Serge Milin
- CHU de Poitiers, Service d'Anatomo-cytopathologie, Poitiers, France
| | - Karline Guilloteau
- INSERMU935, Modèles de cellules souches malignes et thérapeutiques, Poitiers, France. Université de Poitiers, Poitiers, France. CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France
| | - Thibaut Legigan
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux, Groupe «Systèmes Moléculaires Programmés, Poitiers, France
| | - Pierre Rivet
- CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France
| | - Odile Boissonnade
- CHU de Poitiers, Service d'Oncologie Radiotherapique, Poitiers, France
| | - Sébastien Martin
- CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France
| | - Caroline Tripiana
- CHU de Poitiers, Service d'Oncologie Radiotherapique, Poitiers, France
| | - Michel Wager
- CHU de Poitiers, Service de Neurochirurgie, Poitiers, France
| | | | - Sébastien Papot
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux, Groupe «Systèmes Moléculaires Programmés, Poitiers, France
| | - Lucie Karayan-Tapon
- INSERMU935, Modèles de cellules souches malignes et thérapeutiques, Poitiers, France. Université de Poitiers, Poitiers, France. CHU de Poitiers, Laboratoire de Cancérologie Biologique, Poitiers, France.
| |
Collapse
|
17
|
Chatzopoulou M, Antoniou A, Pitsinos EN, Bantzi M, Koulocheri SD, Haroutounian SA, Giannis A. A fast entry to furanoditerpenoid-based Hedgehog signaling inhibitors: identifying essential structural features. Org Lett 2014; 16:3344-7. [PMID: 24895068 DOI: 10.1021/ol501370j] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
New, small molecule Hedgehog (Hh) pathway inhibitors, such as the furanoditerpenoid taepeenin D, are of high medicinal importance. To establish key structure-activity relationships (SARs) for this lead, a synthetic sequence has been developed for the expedient preparation of several derivatives and their evaluation as Hh inhibitors exploiting its structural similarity to abietic acid. While C(14) substitution is not essential for biological activity, the presence of a hydrogen bond acceptor at C(6) and an intact benzofuran moiety are.
Collapse
Affiliation(s)
- Maria Chatzopoulou
- NCSR "Demokritos", P.O. Box 60228, GR-153 10 Ag. Paraskevi, Athens, Greece
| | | | | | | | | | | | | |
Collapse
|
18
|
Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, Papot S. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update. Eur J Med Chem 2014; 74:302-13. [PMID: 24480360 DOI: 10.1016/j.ejmech.2013.12.045] [Citation(s) in RCA: 71] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2013] [Revised: 12/22/2013] [Accepted: 12/23/2013] [Indexed: 02/07/2023]
Abstract
The design of novel antitumor agents allowing the destruction of malignant cells while sparing healthy tissues is one of the major challenges in medicinal chemistry. In this context, the use of non-toxic prodrugs programmed to be selectively activated by beta-glucuronidase present at high concentration in the microenvironment of most solid tumors has attracted considerable attention. This review summarizes the major progresses that have been realized in this field over the past ten years. This includes the new prodrugs that have been designed to target a wide variety of anticancer drugs, the prodrugs employed in the course of a combined therapy, the dendritic glucuronide prodrugs and the concept of β-glucuronidase-responsive albumin binding prodrugs.
Collapse
Affiliation(s)
- Isabelle Tranoy-Opalinski
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France
| | - Thibaut Legigan
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France
| | - Romain Barat
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France
| | - Jonathan Clarhaut
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France; INSERM CIC 0802, CHU de Poitiers, 2 rue de la Milétrie, 86021 Poitiers, France
| | - Mikaël Thomas
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France
| | - Brigitte Renoux
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France
| | - Sébastien Papot
- Université de Poitiers, UMR-CNRS 7285, Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP), Groupe "Systèmes Moléculaires Programmés", 4 rue Michel Brunet, 86022 Poitiers, France.
| |
Collapse
|
19
|
Manetti F, Taddei M, Petricci E. Structure–Activity Relationships and Mechanism of Action of Small Molecule Smoothened Modulators Discovered by High-Throughput Screening and Rational Design. TOPICS IN MEDICINAL CHEMISTRY 2014. [DOI: 10.1007/7355_2014_61] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
20
|
Stachulski AV, Meng X. Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides. Nat Prod Rep 2013; 30:806-48. [DOI: 10.1039/c3np70003h] [Citation(s) in RCA: 70] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
21
|
Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy. Angew Chem Int Ed Engl 2012; 51:11606-10. [DOI: 10.1002/anie.201204935] [Citation(s) in RCA: 78] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2012] [Revised: 07/16/2012] [Indexed: 11/06/2022]
|
22
|
The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201204935] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
23
|
Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S. Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin. J Med Chem 2012; 55:4516-20. [PMID: 22515366 DOI: 10.1021/jm300348r] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
In this paper we describe the synthesis and biological evaluation of the first β-glucuronidase-responsive albumin-binding prodrug designed for the selective delivery of doxorubicin at the tumor site. This prodrug leads to superior antitumor efficacy in mice compared to HMR 1826, a well-known glucuronide prodrug of doxorubicin that cannot bind covalently to circulating albumin. Furthermore, this compound inhibits tumor growth in a manner similar to that of doxorubicin while avoiding side effects induced by the free drug.
Collapse
Affiliation(s)
- Thibaut Legigan
- Institut de Chimie des Milieux et des Matériaux de Poitiers, IC2MP, Université de Poitiers, UMR-CNRS 7285, 4 Rue Michel Brunet, 86022 Poitiers, France
| | | | | | | | | | | | | | | |
Collapse
|